1. Home
  2. DCTH vs NML Comparison

DCTH vs NML Comparison

Compare DCTH & NML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • NML
  • Stock Information
  • Founded
  • DCTH 1988
  • NML 2012
  • Country
  • DCTH United States
  • NML United States
  • Employees
  • DCTH N/A
  • NML N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • NML Finance/Investors Services
  • Sector
  • DCTH Health Care
  • NML Finance
  • Exchange
  • DCTH Nasdaq
  • NML Nasdaq
  • Market Cap
  • DCTH 518.0M
  • NML 454.4M
  • IPO Year
  • DCTH N/A
  • NML N/A
  • Fundamental
  • Price
  • DCTH $11.87
  • NML $8.21
  • Analyst Decision
  • DCTH Strong Buy
  • NML
  • Analyst Count
  • DCTH 4
  • NML 0
  • Target Price
  • DCTH $22.75
  • NML N/A
  • AVG Volume (30 Days)
  • DCTH 458.0K
  • NML 219.3K
  • Earning Date
  • DCTH 05-13-2025
  • NML 01-01-0001
  • Dividend Yield
  • DCTH N/A
  • NML 9.75%
  • EPS Growth
  • DCTH N/A
  • NML N/A
  • EPS
  • DCTH N/A
  • NML N/A
  • Revenue
  • DCTH $37,205,000.00
  • NML N/A
  • Revenue This Year
  • DCTH $128.78
  • NML N/A
  • Revenue Next Year
  • DCTH $54.07
  • NML N/A
  • P/E Ratio
  • DCTH N/A
  • NML N/A
  • Revenue Growth
  • DCTH 1701.69
  • NML N/A
  • 52 Week Low
  • DCTH $5.04
  • NML $6.09
  • 52 Week High
  • DCTH $16.97
  • NML $7.33
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 47.65
  • NML 38.94
  • Support Level
  • DCTH $11.05
  • NML $7.70
  • Resistance Level
  • DCTH $11.84
  • NML $8.50
  • Average True Range (ATR)
  • DCTH 0.97
  • NML 0.43
  • MACD
  • DCTH 0.09
  • NML -0.02
  • Stochastic Oscillator
  • DCTH 57.89
  • NML 42.06

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About NML Neuberger Berman Energy Infrastructure and Income Fund Inc.

Neuberger Berman Energy Infrastructure & Income Fund Inc is a closed-end investment management company based in the United States. Invest in Capital Markets, Chemicals, Oil, Gas & Consumable Fuels, Electric Utilities, Independent Power and Renewable Electricity Producers, Multi Utilities. Maximum is done in Oil, Gas & Consumable Fuels.

Share on Social Networks: